期刊文献+

乳腺癌组织Livin和PTEN表达与肿瘤血管生成的相关性 被引量:12

The correlations between expression of Livin and PTEN and angiogenesis of breast cancer
暂未订购
导出
摘要 目的:研究乳腺癌组织中凋亡抑制蛋白Livin和抑癌基因PTEN的表达与微血管密度(MVD)的关系,探讨乳腺癌血管生成的影响机制。方法:应用免疫组化Elivision法检测90例乳腺癌和30例乳腺纤维腺瘤组织中Livin、PTEN、VEGF的表达和CD34标记的MVD值,分析Livin和PTEN表达与乳腺癌血管生成及侵袭转移的关系。结果:在90例乳腺癌中Livin、PTEN和VEGF表达阳性率分别为54.4%、48.9%和61.1%,MVD为(30.81±11.29)个/HPF,与良性对照组比较均有显著差异(P<0.01);Livin阳性表达与乳腺癌肿瘤大小、临床分期、MVD值及VEGF表达呈正相关(P<0.05),与年龄、病理分级、淋巴结转移未见显著相关(P>0.05);PTEN表达与乳腺癌淋巴结转移、临床分期和MVD呈负相关(P<0.05),与VEGF表达、年龄、肿瘤大小、病理分级未见显著相关(P>0.05)。结论:Livin和PTEN在乳腺癌的血管生成及发生发展过程中分别起促进和抑制作用,Livin的促血管生成作用可能与其上调VEGF的表达有关。 Objective:To investigate the expression of inhibitor of apoptosis protein Livin and tumor suppressor gene PTEN and its association with the microvessel density(MVD),and to study the mechanism of angiogenesis in breast cancer tissues.Methods:Expressions of Livin,PTEN,VEGF and MVD marked with CD34 were examined by Elivision immunohistochemistry in 90 cases of breast cancer tissues and 30 cases of breast fibroadenoma tissues for analyzing the relationships between expression of Livin and PTEN and angiogenesis,invasion and metastasis of breast cancer.Results:In 90 cases of breast cancer,the expression positive incidences of Livin,PTEN and VEGF were respectively 54.4%,48.9%,and 61.1%,the MVD was(30.81±11.29)/HPF,which all differentiate apparently those of the benign control group(P〈0.01).In breast cancer tissues,the expression of Livin was positively related to tumor size,clinical stage,MVD and VEGF(P〈0.05),but unapparently related to patients age,histopathologic grade,lymphnode metastasis(P〈0.05).The expression of PTEN was negatively related to lymphnode metastasis,clinical stage and MVD(P〈0.05),but unapparently related to VEGF expression,patients age,tumor size,histopathologic grade(P〉0.05).Conclusion:Livin and PTEN respectively play the roles of promoting and inhibiting in angiogenesis,carcinogenesis and development of breast cancer.Livin can upregulate the expression of VEGF,which may lead to the angiogenesis promoting effect of Livin in breast cancer.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2012年第10期886-889,共4页 Chinese Journal of Immunology
基金 福建省卫生厅青年科研课题(2008-1-47) 福州市科技计划项目(2008-S-79及2004350102000721)资助项目
关键词 乳腺癌 LIVIN PTEN 血管生成 免疫组化 Breast cancer Livin PTEN Angiogenesis Immunohistochemistry
  • 相关文献

参考文献4

  • 1Meyer J S, Alvarez C ,Milikowski C et al. Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproduc?ibility of grade and advantages of proliferation index [ JJ . Mod Pathol, 2005 ; 18 (8) :1067-1078.
  • 2黄玉钿,张声,郑曦,吴钦穗,黄双月.乳腺癌细胞凋亡及侵袭转移与诱导型一氧化氮合酶、抑癌基因PTEN及环氧合酶-2表达的关系[J].中华实验外科杂志,2010(6):714-716. 被引量:9
  • 3Samaranayake H, Maatta AM, Pikkarainen J et al. Future prospects and challenges of antiangiogenic cancer gene therapy [ J ] . Hum Gene Ther ,2010 ;21 (4) :381-396.
  • 4Abd-Elrahman I, Hershko K,Neuman T et al, The inhibitor of apopto?sis protein Livin (ML-IAP) plays a dual role in tumorigenicity [J ] . Cancer Res, 2009 ;69 (13) :5475-5480.

二级参考文献3

共引文献8

同被引文献116

  • 1马丽亚,张颖,庞玉琴,王磊,李宾玲,张大伟.庞氏安胎止血汤对热证自然流产大鼠T细胞亚群表达干预的研究[J].时珍国医国药,2018,29(11):2632-2635. 被引量:10
  • 2傅少梅,殷初阳,宋晖.miR-340在三阴性乳腺癌的表达和意义[J].中国生化药物杂志,2014,34(1):72-73. 被引量:3
  • 3阿斯楞,仝林虎,苏秀兰.CD105在大肠癌中的表达及临床意义[J].内蒙古医学院学报,2006,28(3):204-208. 被引量:2
  • 4张宏艳,宋三泰,江泽飞,郑晓玲,黄焰,李刚.乳腺癌组织中PTEN的表达及其临床意义[J].解放军医学杂志,2006,31(10):963-965. 被引量:7
  • 5Maehama T, Dixon JE. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate[ J]. J Biol Chem, 1998,273 ( 22 ) : 13375- 13378.
  • 6Fabi A, Metro G, Di BA, et al. Clinical significanee of PTEN and p-Akt co-expression in HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies [ J ]. Oncology,2010,78(2) : 141-149.
  • 7Pires MM, Hopkins BD, Saal LH, et al. Alterations of EGFR, p53 and PTEN that mimic changes found in basal-like breast cancer promote transformation of human mammary epithelial cells [J]. Cancer Biol Ther, 2013,14(3) : 246-253.
  • 8Heering J, Erlmann P, Olayioye MA. Simultaneous loss of the DLC1 and PTEN tumor suppressors enhances breast cancer cell migration[J]. Exp Cell Res,2009,315(15) : 2505-2514.
  • 9Depowski PL, Rosenthal SI, Ross JS. Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer[J]. Mod Pathol.2001.14(7) .. 672-676.
  • 10Neto JC, Ikoma MM, Carvalho KC, et al. MGMT and PTEN as potential prognostic markers in breast cancer [ J ]. Exp Mol Pathol,2012,92( 1 ) : 20-26.

引证文献12

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部